Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments - 19/08/22

Ge Peng, MD ^{a, b}, Ko Okumura, MD, PhD ^b, Hideoki Ogawa, MD, PhD ^b, Shigaku Ikeda, MD, PhD ^{a, b}, François Niyonsaba, MD, PhD ^{b, c, ⁎}

^a Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan 

^b Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan 

^c Faculty of International Liberal Arts, Juntendo University, Tokyo, Japan 

^∗Correspondence and reprint requests to: François Niyonsaba, MD, PhD, Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421 JapanAtopy (Allergy) Research CenterJuntendo University Graduate School of Medicine2-1-1 HongoTokyoBunkyo-Ku113-8421Japan